| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Oct-08 | | Total Revenue | 205 | 191 | 199 | 239 | | Cost of Revenue | 657 | 633 | 769 | 1,891 | | | Gross Profit | (452) | (442) | (570) | (1,652) | | | Operating Expenses | | Research Development | 441 | 742 | 828 | 1,216 | | Selling General and Administrative | 1,451 | 1,932 | 1,592 | 3,200 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,344) | (3,116) | (2,990) | (6,068) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11 | 13 | 11 | 98 | | Earnings Before Interest And Taxes | (2,333) | (3,103) | (2,979) | (5,970) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (2,333) | (3,103) | (2,979) | (5,970) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,333) | (3,103) | (2,979) | (5,970) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,333) | (3,103) | (2,979) | (5,970) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,333) | ($3,103) | ($2,979) | ($5,970) |
|
0.31% Nasdaq 0.00%
0.003 (1.19%) 
Income Statement
